StarTalk Radio: Curing All Disease with AI with Max Jodeberg

Episode Information:

• Title: Curing All Disease with AI
• Host: Neil deGrasse Tyson
• Guest: Max Jodeberg, Chief AI Officer at Isomorphic Labs
• Release Date: May 30, 2025

Introduction to AI in Biology

The episode opens with host Neil deGrasse Tyson introducing the central theme: the transformative role of Artificial Intelligence (AI) in biology and medicine. Tyson emphasizes that while AI has made headlines for outperforming humans in games like chess and Jeopardy, its real potential lies in solving complex biological problems.

Neil deGrasse Tyson [02:07]: "AI was not satisfied. Just whooping our ass in chess and in jeopardy and everything else where it looks like brains mattered, it's now taken over our physiology."

Guest Introduction: Max Jodeberg

Neil welcomes Max Jodeberg, whose expertise in AI, particularly in deep learning algorithms, has positioned him at the forefront of applying AI to biological challenges. Max's background includes significant contributions at Google DeepMind, where he worked on projects like AlphaFold—an AI system adept at predicting protein structures.

Neil deGrasse Tyson [05:51]: "Neil searched his 9,000 images on his computer for the word 'telescope' and it found 'telescope' written in Chinese on a photo taken at an angle during his visit to China."

Understanding Protein Folding with AlphaFold

Max delves into the intricacies of protein folding—a fundamental biological process where proteins adopt specific three-dimensional structures essential for their function. Misfolded proteins can lead to various diseases, making accurate prediction of protein structures crucial.

Max Jodeberg [11:09]: "Proteins are these fundamental building blocks of life... they fold up spontaneously in the cell to create these 3D shapes."

Evolution of AlphaFold: From Discovery to Drug Design

The conversation shifts to the development of AlphaFold, highlighting its evolution from AlphaFold 2, which achieved Nobel recognition, to AlphaFold 3. The latest iteration not only predicts protein structures with near-experimental accuracy but also integrates interactions with other biomolecules like DNA and RNA, expanding its applicability in drug discovery.

Max Jodeberg [21:04]: "AlphaFold2 reached experimental-level accuracy for proteins, and AlphaFold 3 expands to incorporate other biomolecular types."

Revolutionizing Drug Discovery

Max explains how AI, through technologies like AlphaFold 3, is revolutionizing the traditional drug discovery process. Instead of the conventional method of randomly testing millions of molecules—a process both time-consuming and costly—AI enables the rational design of drugs by accurately modeling protein-drug interactions.

Max Jodeberg [22:35]: "We can start actually rationally designing these drugs... instead of taking a million random molecules and throwing them at these proteins, AI can model thousands in minutes."

This shift not only accelerates the discovery pipeline but also significantly reduces the average cost of developing a new drug, estimated traditionally at around $3 billion.

Max Jodeberg [27:17]: "It costs on average $3 billion to create a new drug."

Personalized Medicine and Future Applications

The discussion moves towards personalized medicine, where AI-driven drug design can lead to bespoke medications tailored to an individual's genetic makeup. This approach promises treatments with higher efficacy and minimal side effects, moving beyond the one-size-fits-all model prevalent today.

Max Jodeberg [35:11]: "Imagine a world where we can sequence your particular cancer mutations and generate specific drugs for you."

Additionally, AI's capabilities extend to broader scientific applications, such as engineering bacteria to digest plastics or enhancing crop resilience, showcasing its versatility across various fields.

Max Jodeberg [53:15]: "People are using this to create bacteria with enzymes that could potentially digest plastics... more resilient types of crops."

Challenges and Ethical Considerations

Despite the promising advancements, the panel acknowledges challenges, including the vast chemical space (estimated at 10^60 possible molecules) that remains computationally unfeasible to navigate without sophisticated AI models. Furthermore, ethical considerations surrounding AI's role in drug design and potential misuse necessitate robust guardrails.

Max Jodeberg [25:15]: "We need something that we call a generative model or an agent, which is able to search through that space and come up with molecule designs for you."

Max Jodeberg [54:09]: "You need to think about how to use this responsibly... what you're putting out into the world openly versus what you close off for many safety reasons."

The Future Landscape: Quantum Computing and Beyond

The conversation touches upon the synergy between AI and emerging technologies like quantum computing, which could further enhance AI's ability to model complex biological systems. Max envisions a future where AI, empowered by quantum computing, could simulate entire cellular environments, unlocking unprecedented scientific discoveries.

Max Jodeberg [52:29]: "Quantum computers could simulate small chemical systems more efficiently, enhancing our understanding of molecular properties."

Conclusion: The Dawn of a New Frontier

As the episode draws to a close, Neil deGrasse Tyson reflects on the monumental changes AI is bringing to biology and medicine. With pioneers like Max Jodeberg leading the charge, the potential to cure diseases, design personalized medications, and revolutionize entire scientific disciplines appears within reach.

Neil deGrasse Tyson [55:17]: "We're looking through your lens at the birth of an entire frontier in human physiology. What a time this is."

Notable Quotes:

• Neil deGrasse Tyson [02:07]: "AI was not satisfied. Just whooping our ass in chess and in jeopardy and everything else where it looks like brains mattered, it's now taken over our physiology."

• Max Jodeberg [27:17]: "It costs on average $3 billion to create a new drug."

• Max Jodeberg [35:11]: "Imagine a world where we can sequence your particular cancer mutations and generate specific drugs for you."

• Max Jodeberg [54:09]: "You need to think about how to use this responsibly... what you're putting out into the world openly versus what you close off for many safety reasons."

Key Takeaways:

1. AI's Role in Biology: AI, especially models like AlphaFold 3, is pivotal in understanding complex biological processes such as protein folding, which is essential for drug discovery and addressing various diseases.

2. Cost and Efficiency: AI-driven drug design significantly reduces the time and financial investment required to develop new medications, potentially lowering the cost burden of healthcare.

3. Personalized Medicine: The integration of AI allows for the creation of personalized treatments tailored to individual genetic profiles, enhancing treatment efficacy and minimizing side effects.

4. Expanding Applications: Beyond drug discovery, AI's capabilities are being leveraged in areas like environmental sustainability and agricultural resilience, demonstrating its versatile impact across scientific disciplines.

5. Ethical Considerations: The rapid advancement of AI in sensitive fields necessitates careful consideration of ethical implications, including data privacy, responsible usage, and safeguarding against potential misuse.

6. Future Technologies: The convergence of AI with emerging technologies like quantum computing promises to further accelerate scientific breakthroughs, albeit accompanied by new challenges and complexities.

This episode of StarTalk Radio offers an insightful exploration into the intersection of AI and biology, highlighting groundbreaking advancements and contemplating the future landscape of medicine and scientific research. Max Jodeberg's expertise provides listeners with a comprehensive understanding of how AI is not just a tool for game-playing but a fundamental enabler for curing diseases and redefining human health.